Apeiron to Start First Clinical Trial in Japan with its Neuroblastoma Therapy APN311

Japanese PMDA approved planned Phase I study which will be locally run by Nagoya University. Press Release Presseaussendung Press Release (Japanese)

July 7, 2014
View the Post